EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Protein nanoparticles as drug delivery systems for cancer theranostics

Yue Hua, Zibo Qin, Lin Gao, Mei Zhou, Yonger Xue, Yue Li, Jinbing Xie

Journal of Controlled Release · 2024-07 · 371 · 429-444

DOI: 10.1016/j.jconrel.2024.06.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024-07. Verfasst von Yue Hua und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250000, China. Hauptthemen laut MEDLINE: Neoplasms, Theranostic Nanomedicine, Nanoparticles, Drug Delivery Systems. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 176 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein-based nanoparticles have garnered significant attention in theranostic applications due to their superior biocompatibility, exceptional biodegradability and ease of functionality. Compared to other nanocarriers, protein-based nanoparticles offer additional advantages, including biofunctionality and precise molecular recognition abilities, which make them highly effective in navigating complex biological environments. Moreover, proteins can serve as powerful tools with self-assembling structures and reagents that enhance cell penetration. And their derivation from abundant renewable sources and ability to degrade into harmless amino acids further enhance their suitability for biomedical applications. However, protein-based nanoparticles have so far not realized their full potential. In this review, we summarize recent advances in the use of protein nanoparticles in tumor diagnosis and treatment and outline typical methods for preparing protein nanoparticles. The review of protein nanoparticles may provide useful new insights into the development of biomaterial fabrication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTheranostic NanomedicineNanoparticlesDrug Delivery SystemsProteinsHumansAnimalsAntineoplastic Agents

Stichwörter der Autor:innen

Protein nanoparticlescancer imagingcancer therapydrug delivery

Substanzen

ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology; Basic Medicine Research and Innovation Center of Ministry of Education; Department of Radiology, Zhongda Hospital, Medi…
  • Center for BioDelivery Sciences, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Rd, Shanghai, 200240, PR China. Electronic address: xue.462@osu.edu.
  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, 999078, Macau SAR, China. Electronic address: kevinyli@um.edu.mo.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hua, Y., Qin, Z., Gao, L., Zhou, M., Xue, Y., Li, Y., & Xie, J. (2024). Protein nanoparticles as drug delivery systems for cancer theranostics. Journal of Controlled Release, 371, 429-444. https://doi.org/10.1016/j.jconrel.2024.06.004

Vancouver

Hua Y, Qin Z, Gao L, Zhou M, Xue Y, Li Y, et al. Protein nanoparticles as drug delivery systems for cancer theranostics. Journal of Controlled Release. 2024;371:429-444. doi:10.1016/j.jconrel.2024.06.004

BibTeX
@article{Hua2024,
  author = {Hua, Yue and Qin, Zibo and Gao, Lin and Zhou, Mei and Xue, Yonger and Li, Yue and Xie, Jinbing},
  title = {Protein nanoparticles as drug delivery systems for cancer theranostics},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {371},
  pages = {429--444},
  doi = {10.1016/j.jconrel.2024.06.004}
}
Kostenlos starten →